Single agent of apatinib in patients with recurrent or refractory cervical cancer: A real-world multicenter retrospective study.

2019 
e17011Background: Few effective treatment strategy has been established for patients with recurrent or refractory cervical cancer. The present study evaluates the efficacy and safety of apatinib si...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []